MXPA03000313A - Uso de fosfato de estramustina en el tratamiento de metastasis osea. - Google Patents
Uso de fosfato de estramustina en el tratamiento de metastasis osea.Info
- Publication number
- MXPA03000313A MXPA03000313A MXPA03000313A MXPA03000313A MXPA03000313A MX PA03000313 A MXPA03000313 A MX PA03000313A MX PA03000313 A MXPA03000313 A MX PA03000313A MX PA03000313 A MXPA03000313 A MX PA03000313A MX PA03000313 A MXPA03000313 A MX PA03000313A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- estramustine phosphate
- bone metastasis
- bone
- metastasis
- Prior art date
Links
- 206010027476 Metastases Diseases 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 229960004750 estramustine phosphate Drugs 0.000 title abstract 2
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title abstract 2
- 230000009401 metastasis Effects 0.000 title abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 2
- 230000024279 bone resorption Effects 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Se muestra que el fosfato de estramustina act°a como inhibidor de reabsorcion osea y por lo tanto puede utilizarse para tratar, prevenir o aliviar los síntomas de metástasis osea que surgen debido a la reabsorcion osea.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/625,540 US6436913B1 (en) | 2000-07-25 | 2000-07-25 | Use of estramustine phosphate in the treatment of bone metastasis |
| PCT/US2001/023179 WO2002007719A1 (en) | 2000-07-25 | 2001-07-23 | Use of estramustine phosphate in the treatment of bone metastasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03000313A true MXPA03000313A (es) | 2003-06-06 |
Family
ID=24506563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03000313A MXPA03000313A (es) | 2000-07-25 | 2001-07-23 | Uso de fosfato de estramustina en el tratamiento de metastasis osea. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6436913B1 (es) |
| EP (1) | EP1328264A4 (es) |
| JP (1) | JP2004504346A (es) |
| KR (1) | KR20030019612A (es) |
| CN (1) | CN1446086A (es) |
| AR (1) | AR029958A1 (es) |
| AU (1) | AU2001277115A1 (es) |
| BR (1) | BR0112721A (es) |
| CA (1) | CA2412392A1 (es) |
| MX (1) | MXPA03000313A (es) |
| PE (1) | PE20020301A1 (es) |
| WO (1) | WO2002007719A1 (es) |
| ZA (1) | ZA200210285B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003201D0 (en) * | 2000-02-11 | 2000-04-05 | Pharmacia & Upjohn Spa | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| IT1318689B1 (it) * | 2000-09-12 | 2003-08-27 | Pharmacia & Upjohn Spa | Uso dell'arginina nella preparazione di un medicamento per lapreparazione e trattamento degli effetti collaterali associati alla |
| US20040014729A1 (en) * | 2001-07-23 | 2004-01-22 | Beryl Asp | Use of estramustine phosphate in the treatment of bone metastasis |
| WO2005000858A2 (en) * | 2003-06-27 | 2005-01-06 | Akira Odani | Bisphosphonate complexes |
| JP2005055881A (ja) * | 2003-07-22 | 2005-03-03 | Fuji Photo Film Co Ltd | 描画方法および描画装置 |
| CN100340296C (zh) * | 2005-02-03 | 2007-10-03 | 山东蓝金生物工程有限公司 | 一种抗癌体内植入剂 |
| WO2011066379A2 (en) * | 2009-11-24 | 2011-06-03 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | METHOD OF REDUCING INTRATUMORAL pHe AND ACID-MEDIATED INVASION |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634691A (en) * | 1980-10-07 | 1987-01-06 | The Procter & Gamble Company | Method for inhibiting tumor metastasis |
| US5597830A (en) | 1994-12-20 | 1997-01-28 | Warner-Lambert Company | Combination chemotherapy |
| CN1636598A (zh) * | 1998-03-27 | 2005-07-13 | 法麦希亚－厄普约翰公司 | 加强静脉内雌莫司汀磷酸盐作用的方法 |
| JP2003503313A (ja) * | 1999-06-03 | 2003-01-28 | ジェシー エル エス オウ | 細胞増殖及び細胞死を変調する方法及び組成物 |
-
2000
- 2000-07-25 US US09/625,540 patent/US6436913B1/en not_active Expired - Fee Related
-
2001
- 2001-07-17 PE PE2001000722A patent/PE20020301A1/es not_active Application Discontinuation
- 2001-07-23 BR BR0112721-7A patent/BR0112721A/pt not_active IP Right Cessation
- 2001-07-23 AR ARP010103500A patent/AR029958A1/es not_active Application Discontinuation
- 2001-07-23 AU AU2001277115A patent/AU2001277115A1/en not_active Abandoned
- 2001-07-23 MX MXPA03000313A patent/MXPA03000313A/es unknown
- 2001-07-23 WO PCT/US2001/023179 patent/WO2002007719A1/en not_active Ceased
- 2001-07-23 EP EP01954900A patent/EP1328264A4/en not_active Withdrawn
- 2001-07-23 CN CN01813244A patent/CN1446086A/zh active Pending
- 2001-07-23 CA CA002412392A patent/CA2412392A1/en not_active Abandoned
- 2001-07-23 KR KR10-2003-7001068A patent/KR20030019612A/ko not_active Withdrawn
- 2001-07-23 JP JP2002513455A patent/JP2004504346A/ja not_active Withdrawn
-
2002
- 2002-12-19 ZA ZA200210285A patent/ZA200210285B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001277115A1 (en) | 2002-02-05 |
| US6436913B1 (en) | 2002-08-20 |
| AR029958A1 (es) | 2003-07-23 |
| ZA200210285B (en) | 2003-12-19 |
| EP1328264A4 (en) | 2004-01-28 |
| BR0112721A (pt) | 2003-06-24 |
| PE20020301A1 (es) | 2002-04-07 |
| KR20030019612A (ko) | 2003-03-06 |
| CA2412392A1 (en) | 2002-01-31 |
| WO2002007719A1 (en) | 2002-01-31 |
| JP2004504346A (ja) | 2004-02-12 |
| EP1328264A1 (en) | 2003-07-23 |
| CN1446086A (zh) | 2003-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| TW200505434A (en) | Therapeutic treatment | |
| MXPA04001876A (es) | Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis. | |
| TR200103216T2 (tr) | Pirimidinon bileşimleri | |
| NO20013554D0 (no) | Antikonvulsive derivater som kan benyttes ved behandling av klusterhodepiner | |
| DK0755249T3 (da) | Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom | |
| AU2002302587A1 (en) | Acne treatment with lipooxigenase inhibitors | |
| MXPA02011288A (es) | Tioacetamidas substituidas. | |
| PT1411916E (pt) | Métodos e materiais para o tratamento de deficiência em testosterona nos homens | |
| AU2001246600A1 (en) | Use of comt inhibitors as analgesics | |
| MXPA03010634A (es) | Uso de inhibidores de proteasoma para tratar trastornos del ojo seco. | |
| IL158738A0 (en) | Novel use of 2-phenyl-substituted imidazotriazinones | |
| MXPA03000313A (es) | Uso de fosfato de estramustina en el tratamiento de metastasis osea. | |
| DK1274426T3 (da) | Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose | |
| GB9626472D0 (en) | New use of comt inhibitors | |
| CA2322967A1 (en) | Prophylactic, therapeutic agent for osteoporosis | |
| AU9352401A (en) | Production process and composition of an enzymatic preparation, and its use for the treatment of domestic and industrial effluents of high fat, protein and/or carbohydrate content | |
| ATE302009T1 (de) | Ubichinon qn zur behandlung von migräneschmerzen | |
| ATE228840T1 (de) | Neue verwendung von ropivacain zur schmerzbehandlung | |
| AP2000001963A0 (en) | Paroxetine ascorbate. | |
| PL367286A1 (en) | Use of nfkb inhibitors to treat dry eye disorders | |
| MXPA04007007A (es) | Uso de inhibidores del intercambiador cloruro/bicarbonato dependiente del sodio para el tratamiento de enfermedades tromboticas e inflamatorias. | |
| TW200605895A (en) | Combination of a selective noradrenaline reuptake inhibitor and a PDEV inhibitor | |
| UA32314A (uk) | Спосіб лікування некротичного панкреатиту | |
| UA32651C2 (uk) | Спосіб напіввідкритої лапаростомії |